Hilltop Holdings Inc. Eli Lilly & CO Transaction History

Hilltop Holdings Inc.

$849 Million
Q2 2024

A detailed history of Hilltop Holdings Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hilltop Holdings Inc. holds 3,356 shares of LLY stock, worth $3.05 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

3,356

Previous 4,381 23.4%

Holding current value

$3.05 Million

Previous $3.41 Million 10.86%

% of portfolio

0.36%

Previous 0.36%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $742,991 - $931,766	-1,025 Reduced 23.4%	3,356 $3.04 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $129,099 - $172,717	218 Added 5.24%	4,381 $3.41 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $82,980 - $97,822	-158 Reduced 3.66%	4,163 $2.43 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $120,411 - $166,006	277 Added 6.85%	4,321 $2.32 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $131,527 - $175,867	375 Added 10.22%	4,044 $1.9 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $57,777 - $67,856	-186 Reduced 4.82%	3,669 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $233,123 - $271,635	725 Added 23.16%	3,855 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $126,004 - $143,594	-425 Reduced 11.95%	3,130 $1.01 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $88,078 - $103,417	316 Added 9.76%	3,555 $1.15 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $76,274 - $94,789	-325 Reduced 9.12%	3,239 $927,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $70,378 - $87,339	-313 Reduced 8.07%	3,564 $984,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $83,100 - $102,266	375 Added 10.71%	3,877 $896,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $29,790 - $38,534	165 Added 4.94%	3,502 $804,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $78,216 - $101,254	476 Added 16.64%	3,337 $623,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $175,990 - $232,877	1,349 Added 89.22%	2,861 $483,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $36,408 - $42,113	249 Added 19.71%	1,512 $224,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $172,298 - $207,359	1,263 New	1,263 $208,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $282,512 - $324,236	-3,732 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $276,951 - $326,923	3,732 New	3,732 $288,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.

Account

Hilltop Holdings Inc. Eli Lilly & CO Transaction History